OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
Alexander Muik, Bonny Gaby Lui, Huitian Diao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Alexander Muik, Bonny Gaby Lui, Huitian Diao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Showing 11 citing articles:
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study
Yun Lin, Peng Wu, Tim K. Tsang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e722-e731
Closed Access | Times Cited: 21
Yun Lin, Peng Wu, Tim K. Tsang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e722-e731
Closed Access | Times Cited: 21
SARS‐COV‐2 Omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do?
Adnan Akif, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 19
Adnan Akif, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 19
Risk evaluation and mitigation strategies for newly detected SARS‐CoV‐2 Omicron BF.7 subvariant: A brief report
Nazmunnahar Nazmunnahar, Iftekhar Ahmed, Md. Rabiul Islam
Health Science Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 13
Nazmunnahar Nazmunnahar, Iftekhar Ahmed, Md. Rabiul Islam
Health Science Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 13
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
Nannan Jiang, Li Wang, Masato Hatta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Nannan Jiang, Li Wang, Masato Hatta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
Sebastian Hoehl, Sandra Ciesek
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 272-273
Open Access | Times Cited: 6
Sebastian Hoehl, Sandra Ciesek
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 272-273
Open Access | Times Cited: 6
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses
Tim Westphal, Maria Mader, Hendrik Karsten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Tim Westphal, Maria Mader, Hendrik Karsten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Circumstance of Omicron Sub Variant BF.7 in India: A Review
Selvaraj Selvamurugan
International Journal of Pharmaceutical Sciences and Medicine (2023) Vol. 8, Iss. 6, pp. 154-170
Open Access
Selvaraj Selvamurugan
International Journal of Pharmaceutical Sciences and Medicine (2023) Vol. 8, Iss. 6, pp. 154-170
Open Access
